Lanxess’ Acquisition of Itibanyl Produtos Especiais (IPEL)


Campos Mello and Radi, Calil e Associados advised on the deal

LANXESS executed the acquisition of Itibanyl Produtos Especiais Ltda. (IPEL). The family-run company with headquarters in Jarinu, São Paulo, is one of Brazil’s leading biocide manufacturers.

No finanial details have been disclosed.

The transaction is still subject to the approval of the responsible antitrust authorities and is expected to be completed in the first quarter of 2020.

In addition to around 100 employees and the production facility, LANXESS is also taking over the Brazilian company’s laboratory facilities. With the acquisition, the specialty chemical company will also gain access to strategic intermediate products.

Campos Mello Advogados (DLA Piper) advised Lanxess Industria de Produtos Quimicos e Plasticos Ltda. with Fabiano Gallo (Picture), Flavia Cerutti, Rafaella Chiachio and Camila Muniz.

Radi, Calil e Associados advised Itibanyl Produtos Especiais Ltda. (IPEL) with Adalberto Calil, Julio Queiroz, Stefanie Crivelaro and Samara Lopes Barbosa de Souza Monaco.

Involved fees earner: Flavia Cerutti Alves Pinto – Campos Mello Advogados; Rafaella Chiachio – Campos Mello Advogados; Fabiano Gallo – Campos Mello Advogados; Adalberto Calil – Radi Calil e Associados; Stefanie de Arruda Crivelaro – Radi Calil e Associados; Julio Antonio Nunes Queiroz – Radi Calil e Associados; Samara Lopes Barbosa de Souza Monaco – Radi Calil e Associados;

Law Firms: Campos Mello Advogados; Radi Calil e Associados;

Clients: Itibanyl Produtos Especiais Ltda.; Lanxess AG;

Author: Ambrogio Visconti.